Annual Shareholders Equity
$88.61 M
-$11.36 M-11.36%
December 31, 2023
Summary
- As of February 10, 2025, RPHM annual stockholders equity is $88.61 million, with the most recent change of -$11.36 million (-11.36%) on December 31, 2023.
- During the last 3 years, RPHM annual shareholders equity has risen by +$130.72 million (+310.40%).
Performance
RPHM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$76.87 M
-$4.37 M-5.38%
June 30, 2024
Summary
- As of February 10, 2025, RPHM quarterly stockholders equity is $76.87 million, with the most recent change of -$4.37 million (-5.38%) on June 30, 2024.
- Over the past year, RPHM quarterly shareholders equity has dropped by -$11.74 million (-13.25%).
Performance
RPHM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RPHM Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.4% | -13.3% |
| 3 y3 years | +310.4% | -38.1% |
| 5 y5 years | +483.1% | +257.8% |
RPHM Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.8% | at low | -47.8% | at low |
| 5 y | 5-year | -39.8% | -147.5% | -54.1% | -163.4% |
| alltime | all time | -39.8% | -147.5% | -54.1% | -163.4% |
Reneo Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $76.87 M(-5.4%) |
| Mar 2024 | - | $81.24 M(-8.3%) |
| Dec 2023 | $88.61 M(-11.4%) | $88.61 M(-22.9%) |
| Sep 2023 | - | $114.94 M(-13.3%) |
| Jun 2023 | - | $132.53 M(+52.2%) |
| Mar 2023 | - | $87.08 M(-12.9%) |
| Dec 2022 | $99.97 M | $99.97 M(-10.8%) |
| Sep 2022 | - | $112.05 M(-9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $124.16 M(-8.2%) |
| Mar 2022 | - | $135.32 M(-8.1%) |
| Dec 2021 | $147.21 M(-449.5%) | $147.21 M(-5.8%) |
| Sep 2021 | - | $156.21 M(-6.8%) |
| Jun 2021 | - | $167.55 M(-443.9%) |
| Mar 2021 | - | -$48.72 M(+15.7%) |
| Dec 2020 | -$42.12 M(+82.1%) | - |
| Dec 2020 | - | -$42.12 M |
| Dec 2019 | -$23.13 M | - |
FAQ
- What is Reneo Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals annual shareholders equity year-on-year change?
- What is Reneo Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Reneo Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of RPHM is $88.61 M
What is the all time high annual shareholders equity for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high annual stockholders equity is $147.21 M
What is Reneo Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, RPHM annual stockholders equity has changed by -$11.36 M (-11.36%)
What is Reneo Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of RPHM is $76.87 M
What is the all time high quarterly shareholders equity for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high quarterly stockholders equity is $167.55 M
What is Reneo Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, RPHM quarterly stockholders equity has changed by -$11.74 M (-13.25%)